Publications
126 results found
Ma R, 2016, Lidocaine spray reduces pain during IUD insertion, Practitioner, Vol: 260, Pages: 9-9, ISSN: 0032-6518
Ma R, 2016, Does vasectomy affect sexual function?, Practitioner, Vol: 260, Pages: 8-8, ISSN: 0032-6518
Ma R, 2016, Recreational use of drugs to enhance sexual performance, Practitioner, Vol: 260, ISSN: 0032-6518
Ma R, 2016, Pill use before or during pregnancy does not raise risk of birth defects., Practitioner, Vol: 260, ISSN: 0032-6518
Ma R, Perera S, 2016, Safer 'chemsex': GPs' role in harm reduction for emerging forms of recreational drug use, British Journal of General Practice, Vol: 66, Pages: 4-5, ISSN: 1478-5242
Ma R, 2016, The alien sex club, British Journal of General Practice, Vol: 66, Pages: 42-42, ISSN: 0960-1643
Ma R, 2015, Is mine a normal size doctor?, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, 2015, Shortfalls in primary care management of HIV, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, 2015, How well do GPs manage STIs?, Practitioner, Vol: 259, ISSN: 0032-6518
Ma RMMN, 2015, Light and shade behindthe opt-out system forthe HIV screening, The lancet HIV, ISSN: 2352-3018
Ma R, 2015, Is rapid HIV testing effective in primary care?, Practitioner, Vol: 259, Pages: 10-11, ISSN: 0032-6518
Ma R, 2015, Hormonal contraception: Practice-based case studies, Clinical Pharmacist, Vol: 7, ISSN: 1758-9061
Combined oral contraceptives are contraindicated in patients who have migraines and smokers aged over 35 years. 'Quick start' regimens, in which regular contraception is started before the woman's next 'normal' period, are available if the woman needs to start contraception immediately. These are also useful for women with irregular menstrual cycles, where such a wait is impractical. Quick start regimens are outside the product licences for hormonal contraception products. Any woman with unscheduled vaginal bleeding needs to check whether she is pregnant, have a risk assessment or tests for sexually transmitted infections, and a vaginal examination, which should include a cervical smear to rule out cancer.
Ma R, 2015, Hormonal contraception: Methods and patient eligibility, Clinical Pharmacist, Vol: 7, ISSN: 1758-9061
Most modern methods of contraception are safe to use for the majority of women. However, there are a few absolute contraindications. The World Health Organization has published Medical Eligibility Criteria (MEC) for contraception use, which give evidence based, concise summaries of contraindications to use of contraceptives, where category 1 has no restriction to use, and category 4 indicates that the condition has unacceptable risk if that method were used. All hormonal contraceptives can be started on up to day five of a normal menstrual cycle without the need for additional contraception. At any other time, a woman may start hormonal contraceptive if it is reasonably certain that she is not pregnant. There are currently three methods available for emergency hormonal contraception: copper intrauterine device (used within five days of unprotected sexual intercourse or within five days from the earliest estimated date of ovulation); levonorgestrel (taken as a 1.5mg single oral dose up to 72 hours after unprotected sexual intercourse); and ulipristal acetate (taken as a 30mg single oral dose up to 120 hours after unprotected sexual intercourse).
Ma R, 2015, Identifying factors associated with unplanned pregnancy, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, 2015, How do patients with STIs inform their partners?, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, 2015, Hormonal contraception use and acquisition of HIV, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, 2015, Hormonal contraceptive prescribing in teenagers rises, Practitioner, Vol: 259, Pages: 12-13, ISSN: 0032-6518
Ma R, 2015, Gay men who use GSN apps to find partners at greater risk of STIs, Practitioner, Vol: 259, ISSN: 0032-6518
Ma R, Brown E, 2015, An evaluation of commissioning arrangements for intrauterine and subdermal contraception services from general practitioners in London, UK, JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, Vol: 41, Pages: 54-59, ISSN: 1471-1893
- Author Web Link
- Cite
- Citations: 1
Ma R, 2014, Exploring women's reasons for requesting termination, Practitioner, Vol: 258, Pages: 10-11, ISSN: 0032-6518
Ma R, 2014, Could urine testing be used to detect cervical HPV infection?, Practitioner, Vol: 258, Pages: 7-12, ISSN: 0032-6518
Ma R, 2014, Improving chlamydia screening in primary care, Practitioner, Vol: 258, Pages: 10-13, ISSN: 0032-6518
Ma R, 2014, HPV vaccination uptake lowest in young women at greatest risk., Practitioner, Vol: 258, ISSN: 0032-6518
Ma R, 2014, Patients endorse opt-out testing for HIV in primary care, Practitioner, Vol: 258, Pages: 11-12, ISSN: 0032-6518
Ma R, 2014, Exploring women's misconceptions about IUDs, Practitioner, Vol: 258, ISSN: 0032-6518
Ma R, 2014, Comparing venous thrombosis risk in COCPs, Practitioner, Vol: 258, ISSN: 0032-6518
Ma R, 2014, Catheters may affect patients' sexual function, Practitioner, Vol: 258, ISSN: 0032-6518
Ma R, 2014, Has the QOF influenced GP prescribing of LARC?, Practitioner, Vol: 258, Pages: 9-10, ISSN: 0032-6518
Ma R, 2013, Do rapid HIV tests improve frequency of testing?, Practitioner, Vol: 257, Pages: 11-12, ISSN: 0032-6518
Ma R, 2013, Exploring young women's reasons for choosing an IUS, Practitioner, Vol: 257, Pages: 12-13, ISSN: 0032-6518
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.